Bone Marrow TransplantationTissue DonorsHistocompatibility TestingTransplantation, HomologousGraft vs Host DiseaseHistocompatibilityBone MarrowBone Marrow CellsGraft SurvivalTransplantation ChimeraWhole-Body IrradiationHematopoietic Stem Cell TransplantationTransplantation ConditioningLeukemiaHematopoietic Stem CellsAnemia, AplasticSurvival AnalysisTransplantation, AutologousRadiation ChimeraLeukocyte TransfusionGraft RejectionHLA AntigensBone and BonesLymphocyte DepletionMice, Inbred C57BLT-LymphocytesRecurrenceImmunosuppressive AgentsHost vs Graft ReactionTransplantation, IsogeneicLiver TransplantationTreatment OutcomeLiving DonorsTransplantation ToleranceLeukemia, Myelogenous, Chronic, BCR-ABL PositiveGraft Enhancement, ImmunologicHematopoiesisImmunosuppressionBone Marrow PurgingKidney TransplantationBlood DonorsBusulfanTime FactorsBone Marrow DiseasesSkin TransplantationHematologic NeoplasmsTransplantation ImmunologyChimerismAcute DiseaseGraft vs Host ReactionPrecursor Cell Lymphoblastic Leukemia-LymphomaCyclophosphamideTissue and Organ ProcurementBone Marrow ExaminationGranulocyte Colony-Stimulating FactorHeart TransplantationActuarial AnalysisDonor SelectionHematopoietic Stem Cell MobilizationLeukemia, Myeloid, AcuteBone Marrow NeoplasmsSpleenColony-Forming Units AssayCombined Modality TherapyCells, CulturedChimeraRemission InductionLeukemia, MyeloidDisease-Free SurvivalMice, Inbred BALB CRetrospective StudiesLymphocyte Culture Test, MixedCell DifferentiationHepatic Veno-Occlusive DiseaseBone RemodelingStem Cell TransplantationCord Blood Stem Cell TransplantationMyelodysplastic SyndromesLymphoma, Non-HodgkinFlow CytometryLymphocyte TransfusionAntigens, CD34LymphocytesSevere Combined ImmunodeficiencySurvival RateHematologic DiseasesMice, Inbred C3HCyclosporineLung TransplantationGraft vs Tumor EffectPancytopeniaGranulocytesImmune ToleranceLeukocyte CountAntineoplastic Combined Chemotherapy ProtocolsBone DensityCarmustineOrgan TransplantationFollow-Up StudiesNuclear Family